There’s something new — and exciting — happening in Neve Shamir. ICON's development is the start of a legendary architectural journey. Construction is in full swing, transforming this ...

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

From indies to tentpoles, this summer movie season promises stories and characters both familiar and brand new. Here are 35 we're most excited about. A summer with strikes in the rearview and Ryan ...

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).

If a morning cup of coffee is an essential part of your daily routine, you don't want to risk a bad brew. A reliable coffee maker (and freshly ground coffee beans) turns your kitchen into a ...

Solaxy is still in the presale phase, and is on track to post one of the best ICO performances of the year after raising more than $33.5 million in early-stage funding. Interested investors can ...

Visit a quote page and your recently viewed tickers will be displayed here.

Recently, the ICO entered its final phase, leaving investors with less than 23 days to get in on this ground level of the project. Interested investors can buy MIND for $0.0037515 apiece through ...

Elevate your React Native applications with the power of customizable vector icons. Ideal for embellishing buttons, logos, and navigation or tab bars, these icons seamlessly integrate into your ...